YuX.; LiuJ.; QiuH.; HaoH.; ZhuJ.; PengS. Combined inhibition of ACK1 and AKT shows potential toward targeted therapy against KRAS-mutant non-small-cell lung cancer. Bosnian Journal of Basic Medical Sciences, 1 Jun. 2020.